(Q54382778)

29 May 2018

title

Clinicopathological and prognostic value of microRNA-21 and microRNA-155 in colorectal cancer. (English)

1 reference

29 May 2018

1 reference

1 reference

Hajime Shibuya

1

1 reference

29 May 2018

Hisae Iinuma

2

1 reference

29 May 2018

Ryu Shimada

3

1 reference

29 May 2018

Atsushi Horiuchi

4

1 reference

29 May 2018

Toshiaki Watanabe

5

1 reference

29 May 2018

publication date

1 January 2010

1 reference

29 May 2018

published in

Oncology

1 reference

29 May 2018

volume

79

1 reference

29 May 2018

issue

3-4

1 reference

29 May 2018

page(s)

313-320

1 reference

29 May 2018

MicroRNAs are novel biomarkers of colorectal cancer

cites work

1 reference

miRNAs, cancer, and stem cell division

21 January 2018

1 reference

Sizing up miRNAs as cancer genes.

21 January 2018

1 reference

Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia

21 January 2018

1 reference

RAS is regulated by the let-7 microRNA family

21 January 2018

1 reference

A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia

21 January 2018

1 reference

A microRNA polycistron as a potential human oncogene

21 January 2018

1 reference

MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis

21 January 2018

1 reference

MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer

21 January 2018

1 reference

MicroRNA-155 functions as an OncomiR in breast cancer by targeting the suppressor of cytokine signaling 1 gene

21 January 2018

1 reference

Elevated expression of microRNAs 155, 203, 210 and 222 in pancreatic tumors is associated with poorer survival

21 January 2018

1 reference

MicroRNA Expression Abnormalities in Pancreatic Endocrine and Acinar Tumors Are Associated With Distinctive Pathologic Features and Clinical Behavior

21 January 2018

1 reference

MicroRNA-21 promotes cell transformation by targeting the programmed cell death 4 gene

21 January 2018

1 reference

MicroRNA-21 down-regulates the expression of tumor suppressor PDCD4 in human glioblastoma cell T98G.

21 January 2018

1 reference

Programmed cell death protein 4 (PDCD4) acts as a tumor suppressor in neuroendocrine tumor cells

21 January 2018

1 reference

Epidermal expression of the translation inhibitor programmed cell death 4 suppresses tumorigenesis.

21 January 2018

1 reference

Pdcd4 inhibits growth of tumor cells by suppression of carbonic anhydrase type II.

21 January 2018

1 reference

Transformation suppressor protein Pdcd4 interferes with JNK-mediated phosphorylation of c-Jun and recruitment of the coactivator p300 by c-Jun

21 January 2018

1 reference

Tumor protein 53-induced nuclear protein 1 expression is repressed by miR-155, and its restoration inhibits pancreatic tumor development

21 January 2018

1 reference

New microRNAs from mouse and human

21 January 2018

1 reference

Altered expression of miR-21, miR-31, miR-143 and miR-145 is related to clinicopathologic features of colorectal cancer

21 January 2018

1 reference

MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells

21 January 2018

1 reference

MicroRNA gene expression deregulation in human breast cancer

21 January 2018

1 reference

MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer

21 January 2018

1 reference

MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma

21 January 2018

1 reference

Regulation of the germinal center response by microRNA-155

21 January 2018

1 reference

MicroRNA-155 modulates the interleukin-1 signaling pathway in activated human monocyte-derived dendritic cells

21 January 2018

1 reference

Unique microRNA molecular profiles in lung cancer diagnosis and prognosis

21 January 2018

1 reference

P53-dependent expression of the stress-induced protein (SIP).

21 January 2018

1 reference

TP53INP1s and homeodomain-interacting protein kinase-2 (HIPK2) are partners in regulating p53 activity.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000323283

1 reference

29 May 2018

1 reference

29 May 2018